Cipla Limited (LUX:CIPLA)

Market Cap	12.20B
Revenue (ttm)	2.94B
Net Income (ttm)	570.90M
Shares Out	n/a
EPS (ttm)	0.71
PE Ratio	21.37
Forward PE	23.77
Dividend	0.11 (0.66%)
Ex-Dividend Date	Aug 1, 2024

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	17.20
Day's Range	n/a
52-Week Range	16.10 - 20.00
Beta	n/a
RSI	46.52
Earnings Date	May 13, 2025

About Cipla

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 27,764
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CIPLA

Financial Performance

In 2024, Cipla's revenue was 271.45 billion, an increase of 6.30% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial numbers in INR